Autres langues Inhalation Sciences Sweden AB Börse Stuttgart

Actions

SE0009983893

Equipement et technologie médicale avancés

Cours en clôture Börse Stuttgart			Varia. 5j.	Varia. 1 janv.
- ^USD	-.--%		-.--%	-

28/08	Inhalation Sciences lève 0,5 million de couronnes via l'exercice de bons de souscription	FW
24/08	Inhalation Sciences Sweden AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

25/08	Inhalation Sciences welcomes visiting scientist Jonah Dibbern from Kiel University
24/08	Inhalation Sciences Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
20/08	Inhalation Sciences to present the compelling results from the FDA-funded evaluation study of DissolvIt® at leading respiratory and inhalation drug development conferences
18/05	Inhalation Sciences Sweden Wins Inhalation Research Services Order
18/05	Inhalation Sciences receives IRS order worth approximately EUR 117,000
18/05	Inhalation Sciences Sweden AB Receives IRS Order Worth Approximately EUR 117,000
11/05	Inhalation Sciences Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2026
24/03	Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
24/03	Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000
24/03	Inhalation Sciences Sweden AB Secures Additional PreciseInhale Service Orders Worth SEK 350,000
27/02	Inhalation Sciences Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
18/02	Inhalation Sciences Sweden AB Receives New Inhalation Research Services Order for DissolvIt Worth Approximately EUR 139,000
18/02	Inhalation Sciences Sweden Wins DissolvIt System Order
18/02	Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000
27/01	Inhalation Sciences Sweden Wins Inhalation Research Service Orders
27/01	Inhalation Sciences Sweden AB Receives New IRS Orders Worth EUR 52,000 from Global Pharmaceutical Companies
27/01	Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies
27/01	Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies
22/12	Inhalation Sciences Sweden Secures Testing Technology Supply Deal
22/12	Inhalation Sciences receives major IRS order for DissolvIt® from leading global pharma company
22/12	Inhalation Sciences Sweden AB Receives Major IRS Order for DissolvIt®? from Leading Global Pharmaceutical Company
11/12	Inhalation Sciences: Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference
11/12	Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference
04/12	Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market
04/12	Inhalation Sciences Sweden AB Receives Purchase Order Worth EUR 160,000 from International Distributor for the US Market